๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease

โœ Scribed by W. Marz; H. Seydewitz; B. Winkelmann; M. Chen; M. Nauck; I. Witt


Book ID
118557663
Publisher
The Lancet
Year
1995
Tongue
English
Weight
334 KB
Volume
345
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Evidence against heterozygous coagulatio
โœ W. Prohaska; H. Mannebach; M. Schmidt; U. Gleichmann; K. Kleesiek ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 327 KB

The aim of our study was to determine the prevalence of the factor V mutation (position 1691 G->A) in patients with angiographically diagnosed coronary artery disease and myocardial infarction and, as a control, in blood donors. This mutation has already been proved to be the main genetic risk facto

Activated protein C resistance and the f
โœ Sifontes, Maria T.; Nuss, Rachelle; Hunger, Stephen P.; Waters, Jill; Jacobson, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB ๐Ÿ‘ 2 views

To determine the prevalence of activated protein C resistance and the factor V Leiden mutation (position 1691, arginine 506 to glutamine substitution) in children with thrombosis, plasma samples from children with thrombosis were tested for activated protein C resistance. DNA was analyzed for the fa